Medtronic, a global leader in healthcare technology, has announced a new strategic partnership with Corsano Health B.V., a pioneering MedTech company specializing in advanced real-time remote patient monitoring solutions. Medtronic will exclusively distribute Corsano Health’s cutting-edge solution in Western Europe for hospital and hospital-at-home use, enhancing remote monitoring capabilities and transforming patient care across healthcare settings. Additional terms of the agreement were not disclosed.

The multi-parameter wearable solution by Corsano Health is a state-of-the-art, medically-certified multi-sensor wearable designed for continuous monitoring of vital signs.¹ With features like heart rate, breathing rate, SpO2, cuffless non-invasive blood pressure monitoring, and ECG, the Corsano™ solution provides clinicians with seamless, real-time data to non-invasively monitor patients anytime, anywhere.¹

By enabling data-driven decision-making, this technology supports the principles of value-based healthcare, ensuring that patients are uninterruptedly monitored throughout the healthcare continuum. Many studies show that continuous monitoring not only helps reduce unplanned critical care readmissions and detect complications but also empowers clinicians with actionable insights to prioritize care and intervene earlier ultimately improving patient outcomes^†2-8. This aligns with the Medtronic Mission to deliver innovative solutions that enhance healthcare delivery, optimize resource utilization, and improve patient management across the continuum of care.

“The Corsano™ multi-parameter wearable will enhance our portfolio of patient monitoring solutions and help to protect more patients in more places. This innovation empowers our healthcare professionals with real-time tracking and predictive analytics designed to inform clinician decision-making.¹ With the Corsano™ multi-parameter wearable solution clinicians instantly connect to real-time patient data through a powerful, flexible monitoring platform. It is a scalable, future-ready solution for hospitals seeking to modernize care by maximizing their monitoring functionality.¹

Together, we are transforming the healthcare landscape, turning aspirations into reality, and forging a future where safety and excellence go hand in hand,” said Marc De Martini, vice president, Western Europe Commercial, Acute Care and Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.

Corsano Health’s CEO, Peter Stas, expressed his enthusiasm for the partnership, stating, “Our mission at Corsano Health is to transform healthcare by delivering actionable insights that enhance patient outcomes—seamlessly, from hospital to home. Through this innovation, we aim to empower clinicians with advanced remote monitoring capabilities to simplify workflows and provide proactive care. Together, we are redefining connected care models to support the evolving needs of healthcare systems, addressing workforce shortages while enabling personalized and efficient patient management at every stage of care.”

This partnership underscores the critical role of continuous monitoring in optimizing patient pathways. The Corsano™ solution’s ability to provide unrestricted access to raw data for AI development further supports the commitment from Medtronic to integrating cutting-edge technology with world-class medical devices.

About Corsano Health 

Corsano Health B.V. is a leading MedTech company that creates, manufactures, and sells advanced real-time remote patient monitoring solutions. With a CE-MDR medically certified system and FDA clearance, the Corsano™ multi-parameter wearable is setting new standards for continuous monitoring, focusing on our mission to lower healthcare costs and support clinical teams in improving outcomes and patient experiences.

About Medtronic 

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit medtronic.com. 

The Corsano™ multi-parameter wearable is manufactured by Corsano Health B.V and distributed by Medtronic. 

The Corsano™ multi-parameter wearable should not be used as the sole basis for diagnosis or therapy and is intended only as an adjunct in patient assessment. 

† Based on studies done on technologies using the same or some of the same features as the Corsano™ multi-parameter wearable and may not be indicative of its performance. 

‡ The Corsano™ multi-parameter wearable device is not intended for use on acutely ill cardiac patients with potential to develop life-threatening arrhythmias, or SpO2 monitoring in conditions of high motion or low perfusion. 

References 

1. Corsano™ multi-parameter wearable monitor IFU. 

2. Eddahchouri Y, Peelen RV, Koeneman M, Touw HR, van Goor H, Bredie SJ. Effect of continuous wireless vital sign monitoring on unplanned ICU admissions and rapid response team calls: a before-and-after study. British Journal of Anaesthesia. 2022 May 1;128(5):857-63. 

3. Becking-Verhaar FL, Verweij RP, de Vries M, Vermeulen H, van Goor H, Huisman-de Waal GJ. Continuous vital signs monitoring with a wireless device on a general ward: a survey to explore nurses’ experiences in a post-implementation period. International Journal of Environmental Research and Public Health. 2023 May 11;20(10):5794. 

4. Rowland BA, Motamedi V, Michard F, Saha AK, Khanna AK. Impact of continuous and wireless monitoring of vital signs on clinical outcomes: a propensity-matched observational study of surgical ward patients. British Journal of Anaesthesia. 2024 Mar 1;132(3):519-27. 

5. Sun L, Joshi M, Khan SN, Ashrafian H, Darzi A. Clinical impact of multi-parameter continuous non-invasive monitoring in hospital wards: a systematic review and meta-analysis. Journal of the Royal Society of Medicine. 2020 Jun;113(6):217-24. 

6. Areia C, King E, Ede J, Young L, Tarassenko L, Watkinson P, Vollam S. Experiences of current vital signs monitoring practices and views of wearable monitoring: A qualitative study in patients and nurses. Journal of advanced nursing. 2022 Mar;78(3):810-22. 

7. Verrillo SC, Cvach M, Hudson KW, Winters BD. Using Continuous Vital Sign Monitoring to Detect Early Deterioration in Adult Postoperative Inpatients. J Nurs Care Qual. 2019 Apr/Jun;34(2):107-113. doi: 10.1097/NCQ.0000000000000350. PMID: 30095509. 

8. Weller GB, Mault J, Ventura ME, Adams J, Campbell FJ, Tremper KK. A Retrospective Observational Study of Continuous Wireless Vital Sign Monitoring via a Medical Grade Wearable Device on Hospitalized Floor Patients. J Clin Med. 2024 Aug 13;13(16):4747. doi: 10.3390/jcm13164747. PMID: 39200889; PMCID: PMC11355593.